
Drugmaker Watson Pharmaceuticals Inc. said Friday that the Food and Drug Administration has approved its testosterone patch Androderm in a smaller size and lower dose. Watson said it will start selling the 2-milligram and 4-milligram patches next month ... FDA OKs new doses of Watson low testosterone patch
No comments:
Post a Comment